Send the following on WhatsApp
Continue to ChatCovaxin showed 81% interim efficacy: Bharat Biotech on Phase 3 results - Business Standard https://www.indiafinancenews.com/covaxin-showed-81-interim-efficacy-bharat-biotech-on-phase-3-results-business-standard/